Seeing Is Believing
Currently out of the existing stock ratings of Whit Mayo, 129 are a BUY (56.58%), 88 are a HOLD (38.6%), 11 are a SELL (4.82%).
Analyst Whit Mayo, currently employed at LEERINK, carries an average stock price target met ratio of 81.79% that have a potential upside of 22.39% achieved within 209 days.
Whit Mayo’s has documented 468 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on AHCO, Adapthealth Corp at 06-Nov-2024.
Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP) at 11/8/2022. The price target of $1.5 was fulfilled within 3 days with a profit of $0.21 (16.28%) receiving and performance score of 54.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$90
$52.18 (137.97%)
$90
1 months 13 days ago
(04-Oct-2024)
2/11 (18.18%)
$34.2 (61.29%)
133
Buy
$76
$38.18 (100.95%)
$83
1 months 18 days ago
(30-Sep-2024)
2/10 (20%)
$12.59 (19.85%)
304
Buy
$94
$56.18 (148.55%)
$94
1 months 28 days ago
(20-Sep-2024)
0/6 (0%)
$17.6 (23.04%)
Hold
$75
$37.18 (98.31%)
$68
3 months 15 days ago
(02-Aug-2024)
9/9 (100%)
$2.63 (3.63%)
95
Buy
$91
$53.18 (140.61%)
$101
6 months ago
(17-May-2024)
1/4 (25%)
$24.65 (37.15%)
70
Which stock is Whit Mayo is most bullish on?
Which stock is Whit Mayo is most reserved on?
What Year was the first public recommendation made by Whit Mayo?